Supernormal histamine release and normal cytotoxic activity of beige (Chédiak-Higashi syndrome) rat mast cells with giant granules. 1993

T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
Department of Pathology, Osaka University Medical School, Japan.

The beige rat is an animal model of the Chédiak-Higashi syndrome. Since mast cells can be easily purified from the peritoneal cavity of rats, we investigated the function of beige rat mast cells with giant granules by using quantitative methods. Beige and normal rat mast cells were sensitized with anti-dinitrophenol (DNP) IgE antibodies and stimulated by DNP conjugated with human serum albumin. The proportion of histamine released to total histamine was significantly greater in beige rat mast cells than in normal rat mast cells. Since the supernormal histamine release of beige rat mast cells was observed after treatment with 12-O-tetradecanoylphorbol 13-acetate, calcium ionophore A23187, substance P or compound 48/80, it appeared to be attributable to the enlargement in granules in beige rat mast cells. Spontaneous cytotoxic activity of mast cells was assayed by incubating purified mast cells with 51Cr-labelled WEHI-164 cells. Both beige and normal rat mast cells showed significant cytotoxic activity, but no significant difference was detectable between beige and normal rat mast cells. Even after IgE-mediated stimulation, no significant difference in cytotoxic activity was detectable between beige and normal rat mast cells either. Giant granules of beige rat mast cells did not appear to influence the cytotoxic activity of mast cells.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D010529 Peritoneal Cavity The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen. Greater Sac,Lesser Sac,Omental Bursa,Bursa, Omental,Cavity, Peritoneal,Sac, Greater,Sac, Lesser
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D002609 Chediak-Higashi Syndrome A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle. Chediak-Steinbrinck-Higashi Syndrome,Oculocutaneous Albinism with Leukocyte Defect,Chediak Higashi Syndrome,Chediak Steinbrinck Higashi Syndrome,Chediak-Steinbrinck-Higashi Syndromes
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015550 Cell Degranulation The process of losing secretory granules (SECRETORY VESICLES). This occurs, for example, in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules by EXOCYTOSIS. Degranulation, Cell
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
February 1975, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
April 2019, International immunopharmacology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
June 2014, Turkish journal of haematology : official journal of Turkish Society of Haematology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
August 1981, The American journal of pathology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
November 1980, Cancer research,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
December 1981, The American journal of pathology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
September 1978, The American journal of pathology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
January 1993, International archives of allergy and immunology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
January 1982, The American journal of pathology,
T Jippo-Kanemoto, and T Kasugai, and A Yamatodani, and H Ushio, and T Mochizuki, and K Tohya, and M Kimura, and M Nishimura, and Y Kitamura
January 1986, The American journal of pathology,
Copied contents to your clipboard!